Sign in

CIK 0001623526

  • Non-accelerated filer
  • Smaller reporting company

Stoke Therapeutics, Inc.

Sign in to watch
Ticker
STOK
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
471144582
Phone
+1 781-430-8200
Business address
45 WIGGINS AVENUE, BEDFORD, MA, 01730
Former names
ASOthera Pharmaceuticals, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Planned sale CHIEF MEDICAL OFFICER sold 8,216 shares at an average $10.02 ($82,342)
  8. 4 Planned sale CHIEF MEDICAL OFFICER sold 26,631 shares at an average $10.02 ($266,953)
  9. 4 Option exercise Director acquired 1,210 shares (option exercise)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market sale Director sold 19,289 shares at an average $8.49 ($163,673)
  15. 4 Open-market sale CHIEF MEDICAL OFFICER sold 7,217 shares at an average $8.49 ($61,238)
  16. 4 Open-market sale GENERAL COUNSEL & CORP SEC sold 4,211 shares at an average $8.49 ($35,731)
  17. 4 Option exercise GENERAL COUNSEL & CORP SEC acquired 13,475 shares (option exercise)
  18. 4 Option exercise CHIEF MEDICAL OFFICER acquired 23,100 shares (option exercise)
  19. 4 Option exercise CEO acquired 61,750 shares (option exercise)
  20. 4 Option exercise CEO acquired 35,000 shares (option exercise)

Page 5 of 16 · 305 filings